JPRN-UMIN000001170已完成4 期
Treatment efficacy of short-term PEG-IFN alpha for chronic hepatitis C patients with genotype 2 and low viral road - GLSG, 2008, Pegasys
Gunma Liver Study Group0 个研究点目标入组 220 人开始时间: 2014年5月1日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 220
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •liver dysfunction with other causes Allergy to Interferon (IFN) during pregnancy Severe comlication-especially, poor hematopoiesis, renal, cardiac or respiratory function
研究者
相似试验
招募中
Unknown
Assessment of efficacy and safety of PEG-IFN alpha-2a administration into patients with chronic hepatitis B on nuleoside analogueChronic hepatitis BJPRN-UMIN000015633Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Defense Medical College100
招募中
不适用
Examination of efficacy and safety of PEG-IFN alpha-2a for the treatment of chronic hepatitis B.chronic hepatitis BJPRN-UMIN000006649Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine100
招募中
不适用
Examination of efficacy and safety of PEG-IFN alpha-2a plus Adefovir dipivoxil for the treatment of chronic hepatitis Bchronic hepatitis BJPRN-UMIN000006659Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine50
招募中
不适用
Therapeutic effect of Peg-IFN therapy combined with RBV and simeprevir(SMV) on patients with chronic hepatitis C - a multicenter studyChronic hepatitis CJPRN-UMIN000013749Division of digestive and lifestyle disease, Kagoshima university graduate school of medical and dental sciences300
已完成
不适用
Therapeutic effect of Peg-IFN therapy combined with RBV and telaprevir(TVR) on patients with chronic hepatitis CChronic hepatitis CJPRN-UMIN000013743Division of digestive and lifestyle disease, Kagoshima university graduate school of medical and dental sciences300
